A simple method for the production of plasmid DNA in bioreactors.
暂无分享,去创建一个
[1] S. Rosenberg,et al. Developing recombinant and synthetic vaccines for the treatment of melanoma. , 1999, Current opinion in oncology.
[2] Dan Ferber,et al. Safer and Virus-Free? , 2001, Science.
[3] Kristala Jones Prather,et al. Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification , 2003 .
[4] R. Langer,et al. Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation. , 2003, Immunology letters.
[5] P. K. Namdev,et al. Effect of oxygen fluctuations on recombinant Escherichia coli fermentation , 1993, Biotechnology and bioengineering.
[6] D. Weiner,et al. Genetic immunization: a new era in vaccines and immune therapeutics , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] Kendall Powell. DNA vaccines—back in the saddle again? , 2004, Nature Biotechnology.
[8] A. Mountain,et al. Gene therapy: the first decade. , 2000, Trends in biotechnology.
[9] S. Gurunathan,et al. DNA vaccines: immunology, application, and optimization*. , 2000, Annual review of immunology.
[10] A. Simon,et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.
[11] I. Virkajärvi,et al. Escherichia coli growth and plasmid copy numbers in continuous cultivations , 1989, Biotechnology Letters.
[12] S. Gurunathan,et al. DNA vaccines: a key for inducing long-term cellular immunity. , 2000, Current opinion in immunology.
[13] N. Restifo,et al. DNA and RNA-based vaccines: principles, progress and prospects. , 1999, Vaccine.